FDG-PET Follow-up of Non-Small Cell Lung Cancer: Not Dead Yet

被引：3
|
作者：
Stirling, Rob G. [1 ]
Zalcberg, John [1 ]
机构：
[1] Monash Univ, Dept Epidemiol & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia
来源：
ANNALS OF THORACIC SURGERY | 2020年 / 109卷 / 05期
关键词：
D O I：
10.1016/j.athoracsur.2019.05.042
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1624 / 1624
页数：1
相关论文
共 50 条
  • [41] FDG-PET in addition to conventional work-up in non-small-cell lung cancer
    van Tinteren, H
    Smit, EF
    Hoekstra, OS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) : 1591 - 1591
  • [42] Pretreatment FDG-PET SUVmax is not a prognostic marker in stage IV non-small cell lung cancer
    Clausen, Malene
    Brittain, Jane
    Loft, Annika
    Langer, Seppo
    Kjaer, Andreas
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [43] FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence
    Croft, DR
    Trapp, J
    Kernstine, K
    Kirchner, P
    Mullan, B
    Galvin, J
    Peterson, MW
    Gross, T
    McLennan, G
    Kern, JA
    LUNG CANCER, 2002, 36 (03) : 297 - 301
  • [44] Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study
    Verboom, P
    van Tinteren, H
    Hoekstra, OS
    Smit, EF
    van den Bergh, JHAM
    Schreurs, AJM
    Stallaert, RALM
    van Velthoven, PCM
    Comans, EFI
    Diepenhorst, FW
    van Mourik, JC
    Postmus, PE
    Boers, M
    Grijseels, EWM
    Teule, GJJ
    Uyl-de Groot, CA
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (11) : 1444 - 1449
  • [45] How effective is FDG-PET in the locoregional lymph node staging of non-small cell lung cancer?
    Türkmen, C
    Yilmazbayhan, D
    Erelel, M
    Halaç, M
    Ece, T
    Durgun, E
    Güllüoglu, M
    Selçuk, NA
    Kalayci, G
    Sönmezoglu, K
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S350 - S350
  • [46] FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer
    Hoopes, D
    Tann, M
    McGarry, R
    Lo, S
    Timmerman, R
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S225 - S225
  • [47] Non-small cell lung cancer in the new millennium: The effect of FDG-PET on stage distribution.
    Goodgame, B.
    Morgensztern, D.
    Grove, L.
    Govindan, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 415S - 415S
  • [48] Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: Analysis of false-positive FDG-PET findings
    Konishi, J
    Yamazaki, K
    Tsukamoto, E
    Tamaki, N
    Onodera, Y
    Otake, T
    Morikawa, T
    Kinoshita, I
    Dosaka-Akita, H
    Nishimura, M
    RESPIRATION, 2003, 70 (05) : 500 - 506
  • [49] FDG-PET imaging in the management of non-small-cell lung cancer
    Salminen, E
    Mac Manus, M
    ANNALS OF ONCOLOGY, 2002, 13 (03) : 357 - 360
  • [50] Small cell lung cancer: role of FDG-PET and PET/CT
    Baum, R. R.
    Prasad, V.
    ONKOLOGE, 2008, 14 (08): : 774 - +
12345